Instructions are at the document 13661 attached.

Work type: Case study
Format: APA
Pages: 5 pages ( 1375 words, Double spaced)
Academic level: Undergrad. (yrs 1-2)
Subject or discipline: Nursing

Title: National standard medication chart’s embedded safety, medication chart

Number of sources: 15

Paper instructions:
Please read the attached 3 files. I also attached NPS MedicineWise national standard
medication charts course learning outcomes. It helps what is the course saying. You don’t need
to complete an online course. I’m already done.

Task 2 Case study for Group A

Amanda is a 29-year-old pregnant woman with a history of asthma. Her baby is 32 weeks gestation. She presented to the Emergency Department with signs and symptoms of severe asthma, including; chest tightness, difficulty breathing, sneezing and coughing, wheezing and headache. Amanda is a non-smoker. Her chest Xray shows an enlarged heart and some prominent lung markings. Pulmonary function testing showed decreased of FEV1, FVC, and PEFR. A physical assessment found Amanda to have tachypnoea (32), tachycardia (100), hypertension (140/92), fever of 38.6°C, hypoxaemia (SpO2 of 95%), abdominal breathing, agitation, diffuse wheezes, diffuse rhonchi, apathy and fatigue.

She was triaged as prompt attention. An intravenous cannula was inserted. Oxygen therapy and cardiac monitoring were commenced. The medication regimen is documented on the national standard medication chart associated with this case study. Refer to this case and the medication chart to respond to Task 2.

Task 2 Template

Complete the questions in the boxes below. The boxes will expand as your type. Submit this completed document along with the completed NPS MedicineWise national standard medication charts course certificate to the Task 2 area on Blackboard.

Q1. Describe three (3 x 150-words) of the national standard medication chart’s embedded safety features, as explained in the NPS MedicineWise online learning course. Relate the safety features to published practice examples. Use relevant academic sources to support your responses (450 words).

Q2. Review the medication chart of the Task 2 case study. Describe each medication’s indication, the relevant pharmacodynamics and pharmacokinetics of each drug (4 x 150-words). Use relevant academic sources to support your responses (600 words).

Q3. Describe three (3 x 100-words) strategies for ensuring safe medication practice in this case. Explain how each approach contributes to patient safety. Support your suggestions with relevant academic references (300-words).

Q4. Create a patient education script using health literacy principles and a person-centred approach (150 words). This response should be written as if you were speaking to the person in the case study.

References

NUR23

1

Assessment Task 2

RUBRIC

Criteria	High Distinction	Distinction	Credit	Pass	Fail
1. Submission of the certificate of completion for the NPS MedicineWise national standard medication charts course (10%)	Certificate of NPS MedicineWise national standard medication charts course completion correctly submitted and indicates successful completion of four core modules and the paediatric module. A percentage of this criterion weighting will be awarded for submissions demonstrating that not all modules in the course were completed. For example, 100% of course completed and 1 final certificate of completion submitted = 10% (HD). 75% of course completed and requisite certificates submitted = 7.5% (Distinction). 65% of course completed and requisite certificates submitted = 6.5% (Credit). 50% of course completed and requisite certificates submitted = 5% (Pass)	Less than 50% of course completed and requisite certificates submitted = 4%-1% (Fail) Certificate of course/module completion not submitted = 0% (Fail).
2. Application of pathophysiological and pharmacotherapy knowledge to the case study, specific to safe medication administration. (10%)	Meaningful synthesis of the relevant pathophysiology related to the case study. Medication safety discussed in-depth related to the pharmacological concepts in the case study.	Thoughtful and informed discussion of the relevant pathophysiology related to the case study. Medication safety comprehensively related to the pharmacological concepts in the case study.	Clear and coherent discussion of the relevant pathophysiology related to the case study. Medication safety synthesised related to the pharmacological concepts in the case study.	Accurately discusses some of the relevant pathophysiology related to the case study. Medication safety accurately related to the pharmacological concepts in the case study.	Incomplete or superficial discussion of the relevant pathophysiology related to the case study. Medication safety inaccurately related to the pharmacological concepts in the case study.
3. Application of the quality use of medicines concepts to the case study, specific to person-centred care. (40%)	Detailed analysis of the principles of medication safety and the quality use of medicines as described in the NPS MedicineWise online learning modules to the case scenario.	Critical analysis of the principles of medication safety and the quality use of medicines as described in the NPS MedicineWise online learning modules to the case scenario.	Logical links are made regarding the principles of medication safety and the quality use of medicines as described in the NPS MedicineWise online learning modules to the case scenario.	Discussion of the principles of medication safety and the quality use of medicines as described in the NPS MedicineWise online learning modules are satisfactory.	A descriptive account of the principles of medication safety and the quality use of medicines as described in the NPS MedicineWise online learning modules to the case scenario with limited synthesis demonstrated
4. Application of Nursing or Midwifery codes and standards to underpin decision making and safe medication practice. (25%)	Exemplary discussion of the codes and standards demonstrating insightful interpretation of them into practice. Meaningful application of the professional codes and standards to person-centred care. Demonstrates insightful conclusions about client needs.	In-depth discussion of the codes and standards demonstrating accurate knowledge of them in practice. Comprehensive application of the professional codes and standards to person-centred care. Demonstrates balanced conclusions about client needs.	Comprehensive discussion of the codes and standards demonstrating understanding of them in practice. Complete application of the professional codes and standards to person-centred care. Conclusions made about client needs are appropriate.	Description of the codes and standards demonstrating application of them in practice. Application of the professional codes and standards to person-centred care are satisfactory. Relevant conclusions are made about client needs.	Limited evidence of knowledge of the codes and standards related to practice. Codes and standards incorrectly applied. No application of the professional codes and standards to person-centred care. Absence/ Inconsistent conclusions relevance to case scenarios
5. Evidence-based argument and justification of decisions, coherent written expression and presentation (10%)	Exemplary academic communication. All responses are fully and clearly supported by several sources of relevant evidence demonstrating analysis. Eleven or more appropriate references cited in the written response.	Advanced academic communication. All responses are fully and clearly supported by evidence, demonstrating synthesis. Ten or more appropriate references cited in the written response.	Proficient academic communication. Responses are generally supported by appropriate evidence with some synthesis cited. Nine or more appropriate references cited in the written response.	Satisfactory academic communication with minor errors only. Responses are supported by evidence; however, critical analysis of evidence needed synthesis in the responses. Eight or more appropriate references cited in the written response.	Academic communication contains several errors. Limited evidence supports the responses or evidence from sources is treated uncritically. Inadequate number of scholarly sources.
6. Referencing style conforms to APA referencing style used at USC. (5%)	All citations met the APA referencing style No citation errors.	Consistent, accurate and complete referencing style with minor errors.	Consistent and complete referencing style with some errors.	Generally consistent in the referencing technique but needs attention to APA style details.	Incorrect referencing style and technique.

1

NPS MedicineWise national standard medication charts course learning outcomes

1. Patient identification, adverse drug reactions and best possible medication history

1.2 Learning outcomes

On completion of this learning module you should be able to:

· identify and document required information for patient identification

· document patient allergies and adverse drug reactions

· describe what information a best possible medication history should contain

· document medicines taken before presentation to hospital.

2. Optimising the use of the National Standard Medication Charts

2.2 Learning outcomes

On completion of this learning module you should be able to:

· demonstrate your understanding of the safety features of the National Standard Medication Charts and how these reduce risk of medication errors

· identify the different sections of the NSMC, including regular medicines, variable dose medicines, PRN medicines, once-only medicines and telephone orders

· describe your role in ensuring clear documentation and communication of medicines related information when using the NSMC.

3. VTE prophylaxis and anticoagulationSCORM package

3.2 Learning outcomes

On completion of this learning module you should be able to:

· identify VTE as a national safety and quality priority

· document your patient’s VTE risk assessment

· demonstrate understanding of safe and correct use of VTE pharmacological and mechanical prophylaxis

· demonstrate understanding of the safe and correct use of warfarin

· demonstrate understanding of safe and correct prescription of oral anticoagulants other than warfarin.

1. Create or login to your account with NPS MedicineWise to access the national standard medication charts 2021 course.

2. Access the NPS MedicineWise national standards medication charts 2021 course from the NPS MedicineWise website

https://learn.nps.org.au/course/index.php?categoryid=75

3. Complete all 4 core modules of the NPS MedicineWise National standards medication charts 2021 course and the paediatric module.

4. Core Module 1: Patient identification, adverse drug reactions and best possible medication history

5. Core Module 2: Optimising the use of the National Standard Medication Charts

6. Core Module 3: VTE prophylaxis and anticoagulation

7. Core Module 4: Medication safety at transitions of care

8. Paediatric Module: Special features of the Paediatric NIMC

Date Medicine (print generic name)

Date

C
on

t

in
ue

o
n

di
sc

ha
rg

e?

Ye
s

/
N

o
D

is
pe

ns
e?

Ye

s
/

N
o

D
ur

at
io

n:
da

ys
Q

ty
:

P
re

sc
ri
b

e
r’
s

si
g

n
a
tu

r

e

:

P
ri
n
t

yo
u
r

n
a
m

e
:

D
a
te

:
P

h
a
rm

a
c
is

t:

D
a
te
:

Route Dose Hourly frequency Max PRN dose/24 hrs
Time

Indication Pharmacy Dose

Route

Prescriber signature Print your name Contact

Sign

Date Medicine (print generic name)
Date
C
on

tin
ue

o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:
Route Dose Hourly frequency Max PRN dose/24 hrs
Time
Indication Pharmacy Dose
Route
Prescriber signature Print your name Contact
Sign
Date Medicine (print generic name)
Date
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:
Route Dose Hourly frequency Max PRN dose/24 hrs
Time
Indication Pharmacy Dose
Route
Prescriber signature Print your name Contact
Sign
Date Medicine (print generic name)
Date
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:
Route Dose Hourly frequency Max PRN dose/24 hrs
Time
Indication Pharmacy Dose
Route
Prescriber signature Print your name Contact
Sign
Date Medicine (print generic name)
Date
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:
Route Dose Hourly frequency Max PRN dose/24 hrs
Time
Indication Pharmacy Dose
Route
Prescriber signature Print your name Contact
Sign
Date Medicine (print generic name)
Date
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:
Route Dose Hourly frequency Max PRN dose/24 hrs
Time
Indication Pharmacy Dose
Route
Prescriber signature Print your name Contact
Sign
Date Medicine (print generic name)
Date
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:
Route Dose Hourly frequency Max PRN dose/24 hrs
Time
Indication Pharmacy Dose
Route
Prescriber signature Print your name Contact
Sign

Facility/service:

Ward/unit:

Medication chart number of
Additional charts

IV fluid
Palliative care

BGL/insulin
Chemotherapy

Acute pain
IV heparin

Other

Once only and nurse initiated medicines and pre-medications
Date

prescribed
Medicine

(print generic name)
Route Dose

Date/time of
dose

Prescriber/Nurse Initiator (NI)
Given by

Time
given

Pharmacy
Signature Print your name

Telephone orders (to be signed within 24 hours of order)
Date
time

Medicine
(print generic name)

Route Dose Frequency
Check initials Prescriber

name
Pres.
sign

Date
Record of administration

Time /
given by

Time /
given by
Time /
given by

Time /
given byN1 N2

Medicines taken prior to presentation to hospital
(Prescribed, over the counter, complementary) Own medicines brought in? Y N Administration aid (specify) ….

………………….

Medicine Dose and frequency Duration Medicine Dose and frequency Duration

GP: Community pharmacy:

Sign: Print: Date: Medicines usually administered by:

D
O

N
O

T
W

R
IT

E
I
N

T
H

IS
B

IN

D

IN
G

M
A

R
G

IN

D
O
N
O
T
W
R
IT
E
I
N
T
H
IS
B
IN
D
IN
G
M
A
R
G
IN

N

IM

C
(a

c
u

te
)

PRN

PRN
PRN
PRN
PRN
PRN
PRN

URN:

Family name:

Given names:

Address:

Date of birth: Sex: M F

Not a valid
prescription unless

tifi

ers present

Affix patient identification label here

As required
PRN

medicines

See front page for details

Year: 20First prescriber to print patient name
and check label correct:

Attach ADR sticker

©
C

o
m

m
o
n
w

ealth
o

f A
u
stralia 2

0
0
5
– A

s am
en

d
ed

2
0
1
9

X

Amanda Singh Dr J Spock

USC Hospital

Emergency Department

21

1 1

Singh

Amanda

24 Railway Lane, Nambour, 4560, QLD

25/12/1991

01345980134598

Regular medicines

Year 20 Date and month

C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:
P
re
sc
ri
b
e
r’
s
si
g
n
a
tu

re
:

P
ri
n
t
yo
u
r
n
a
m
e
:
D
a
te
:
P
h
a
rm
a
c
is
t:

D
a
te
:

PRESCRIBER MUST ENTER administration times

Date Medicine (print generic name)

Route Dose Frequency and NOW enter times

Indication Pharmacy

Prescriber signature Print your name Contact
Date
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q

ty
:Route Dose Frequency and NOW enter times

Indication Pharmacy
Prescriber signature Print your name Contact
Date
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:Route Dose Frequency and NOW enter times
Indication Pharmacy
Prescriber signature Print your name Contact
Date
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:Route Dose Frequency and NOW enter times
Indication Pharmacy
Prescriber signature Print your name Contact
Date Medicine (print generic name)
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:Route Dose Frequency and NOW enter times
Indication Pharmacy
Prescriber signature Print your name Contact
Date Medicine (print generic name)
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:
Route Dose Frequency and NOW enter times
Indication Pharmacy
Prescriber signature Print your name Contact

Pharmaceutical review:

Tick if
slow

release

Tick if
slow
release
Tick if
slow
release
Tick if
slow
release
Tick if
slow
release
Tick if
slow
release
Regular medicines
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:
P
re
sc
ri
b
e
r’
s
si
g
n
a
tu
re
:
P
ri
n
t
yo
u
r
n
a
m
e
:
D
a
te
:
P
h
a
rm
a
c
is
t:

D
a
te
:

Year 20 Date and month
Variable dose medicine Drug level
Date Medicine (print generic name) Time level taken

Dose
Route Frequency

Prescriber to enter dose times and individual dose

Prescriber

Indication Pharmacy Time to be given:

………………….

Prescriber signature Print your name Contact

Time given

VTE risk assessed: Yes Prophylaxis not required Contraindicated Signature: Date:
Date Medicine (print generic name)

Route Dose Frequency and NOW enter times

Indication

VTE prophylaxis
Pharmacy

Prescriber signature Print your name Contact

Mechanical prophylaxis

Prescriber/NI signature Print your name Contact

C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:

AM
check

PM
check

Date
Warfarin Marevan / Coumadin select brand

Route Prescriber to enter
individual doses

Target INR Range

Indication Pharmacy
Prescriber signature Print your name Contact
PRESCRIBER MUST ENTER administration times

INR
Result

C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q

ty
:Dose mg mg mg mg mg mg mg mg mg mg mg

Prescriber

1600
Initial 1

Initial 2

Date Medicine (print generic name)

Co
nt

in
ue
o
n
di
sc
ha
rg

e?
Y

es
/

N
o

D
is

pe
ns

e?

Ye
s

/ N
o

D
ur
at
io
n:
da
ys
Q
ty
:
Route Dose Frequency and NOW enter times
Indication Pharmacy
Prescriber signature Print your name Contact
Date Medicine (print generic name)
Co
nt
in
ue
o
n
di
sc
ha
rg
e?
Y
es
/
N
o
D
is
pe
ns
e?

Ye
s
/ N
o
D
ur
at
io
n:
da
ys
Q
ty
:
Route Dose Frequency and NOW enter times
Indication Pharmacy
Prescriber signature Print your name Contact
Date Medicine (print generic name)
C
on
tin
ue
o
n
di
sc
ha
rg
e?

Ye
s
/
N
o
D
is
pe
ns
e?

Ye
s
/
N
o
D
ur
at
io
n:
da
ys
Q
ty
:
Route Dose Frequency and NOW enter times
Indication Pharmacy
Prescriber signature Print your name Contact
Pharmaceutical review:

Recommended
administration times

Guidelines only

Morning Mane

0800

Night Nocte 1800 or 2000

Twice
a day BD 0800 2000

Three times
a day TDS 0800 1400 2000

Regular
6 hourly 6 hrly 0600 1200 1800 2400

Regular
8 hourly 8 hrly 0600 1400 2200

Four times
a day QID 0600 1200 1800 2200

Reason for not
administering

Codes MUST be circled

Absent

Fasting

Refused – notify prescriber

Vomiting

On leave

Not available – obtain supply
or contact prescriber

Withheld – enter reason in
clinical record

Self administered

SR = Sustained, modified
or controlled release
formulation.

If scored tablet, then half
can be given.

Dose must be swallowed
without crushing.

Tick if
slow

release
URN:
Family name:
Given names:
Address:

Date of birth: Sex: M F

Not a valid
prescription unless
ers present

Affix patient identification label here and overleaf

Allergies and adverse drug reactions (ADR)
Nil known Unknown (tick appropriate box or complete details below)

Medicine (or other) Reaction / type / date Initials

Sign Print Date

First prescriber to print patient name
and check label correct: Weight (kg): Height (cm):

Tick if
slow
release
Tick if
slow
release
Tick if
slow
release
Attach ADR sticker

Anticoagulant education record
Medicine:

Education

Provided Declined

Not appropriate

Written information

Provided Declined

Written information provided:
CMI Other:

Signature:

Designation: Date:

21 xx
xx

IM

????

Julie Spock 3161JSpock

xx/xx/21

0800

inhale

????
Julie Spock 3161JSpock
xx/xx/21

IV

????
0800
X

65 167

X

Julie Spock xx/xx/21JSpock

JSpock Julie Spock 3161

21

Amanda Singh JSpock

xx/xx/21

0134598

Singh
Amanda
24 Railway Lane, Nambour, 4560, QLD
25/12/1991

x JSpock xx/xx/21

Betamethasone

Salmeterol

Flucloxacillin

5.7 mg Once a week on Monday

50 microg daily

500 mg 6 hrly

0000

0600

1200
1800

X
X

xx/xx/21 0.9% Normal Saline

NEB QID

0600

1200
1800
2200

5mls

????
JSpock Julie Spock 3161